2021 / 05

Next Paper
DOI: 10.24075/brsmu.2021.052

CLINICAL CASE

Moyamoya disease as a possible cause of ischemic stroke in adult patients

Vishnyakova AYu1, Rostovtseva TM1, Kovrazhkina EA1, Golovin DA1, Gubsky IL1, Lelyuk SE2, Lelyuk VG1
About authors

1 Federal Center of Brain Research and Neurotechnologies, Moscow, Russia

2 Russian Medical Academy of Continuous Professional Education, Moscow, Russia

Correspondence should be addressed: Anastasia Yu. Vishnyakova
Ostrovityanova 1, str. 10, Moscow, 117997; ur.xednay@uahsiv

About paper

Funding: the study was part of the State Assignment 056-00171-19-01. Topic ID: АААА-А19-119042590018-0 (March 29, 2019).

Author contribution: Vishnyakova AYu — literature analysis, imaging, data analysis and interpretation, manuscript preparation; Rostovtseva TM — imaging, data analysis and interpretation, figures; Kovrazhkina EA — clinical examination; Golovin DA — imaging; Gubsky IL — data analysis and interpretation; Lelyuk SE — manuscript editing; Lelyuk VG — study concept, manuscript editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of FSBI Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency (Protocol dated October 4, 2021). All patients gave informed consent to participate in the study.

Received: 2021-09-29 Accepted: 2021-10-13 Published online: 2021-10-31
|
  1. Osborn AG, Zalcman KL, Zaveri MD. Luchevaja diagnostika. Golovnoj mozg. M.: Izdatel'stvo Panfilova, 2018; 1216 s. Russian.
  2. Korshunov AE, Pronin IN, Golovteev AL. Bolezn' mojamoja — izlechimaja prichina povtornyh ishemicheskih insul'tov u detej. Russkij zhurnal detskoj nevrologii. 2010; V (1): 27–34. Russian.
  3. Shulgina AA, Lukshin VA, Korshunov AE, Usachev DYu, Pronin IN. Sochetanie kombinirovannoj dvustvol'noj prjamoj i neprjamoj revaskuljarizacii golovnogo mozga s dvuh storon v lechenii bolezni mojamoja. Voprosy nejrohirurgii imeni N. N. Burdenko, 2020; 84 (2): 93–102. Russian.
  4. Takeuchi K, Shimizu K. Hypoplasia of the bilateral internal carotid arteries. Brain Nerve. 1957; 9: 37–43.
  5. Nishimoto A, Takeuchi S. Abnormal cerebrovascular network related to the internal carotid arteries. J Neurosurg. 1967; 29: 255–60.
  6. Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis). Research Committee on the Pathology and Treatment of Spontaneous occlusion of Spontaneous Occlusion of the Circal of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases. Neurol Med Chir (Tokio). 2012; 52: 245–66.
  7. Wanebo JE, Khan N, Zabramski JM Spetzler RF, ed. Moyamoya disease: diagnosis and treatment. New York Stuttgart: Thieme, 2013; 224 p.
  8. Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke. 1983; 14: 50–58.
  9. Newell DW, Abdu E. Moyamoya Disease: Current Concepts. Cureus. 2012; 4 (6): e47. DOI: 10.7759/cureus.47.
  10. Ge P, Zhang Q, Ye X, Liu X Deng X Wang J, et al. Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant. BMC Neurology. 2020; 20: 308. DOI: 10.1186/s12883-020-01884-0.
  11. Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969; 20: 288–99.
  12. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011; 56 (1): 34–40. DOI: 10.1038/jhg.2010.132.
  13. Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S. A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med. 2016; 21: 55–70. DOI: 10.1007/s12199-015-0498-7.
  14. Park YS, An HJ, Kim JO, Kim WS, Han IB, Kim OJ, et al. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea. Int J Mol Sci. 2017; 18 (11): 2477. DOI: 10.3390/ijms18112477.
  15. Fujimura M, Tominaga T. Diagnosis of moyamoya disease: international standard and regional differences. Neurol Med Chir (Tokyo). 2015; 55 (3): 189–93. DOI: 10.2176/nmc.ra.2014-0307.
  16. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008; 39 (12): 3193–200. DOI: 10.1161/ STROKEAHA.107.513408.
  17. Savolainen M, Mustanoja S, Pekkola J, Tyni T, Uusitalo AM, Ruotsalainen S, et al. Moyamoya angiopathy: long-term follow-up study in a Finnish population. J Neurol. 2019; 266 (3): 574–81. DOI: 10.1007/s00415-018-9154-7.
  18. Acker G, Fekonja L, Vajkoczy P. Surgical Management of Moyamoya Disease. Stroke. 2018; 49 (2): 476–82. DOI: 10.1161/ STROKEAHA.117.018563.